前列腺增生的诊断与鉴别诊断(5)
7.McConnell JD: Epidemiology, etiology, pathophysiology and diagnosis of benign prostatic hyperplasia. In Walsh, et al, eds: Campbell's Urology, 7th ed. Philadelphia, W.B. Saunders Company, 1998, pp 1429-1452.
8.Schafer W, Noppeney R, Rhbben H, et al: The value of free flow rate and pressure/flow-study in the routine investigation of BPH patients. Neurourol Urodyn 1988; 7: 219-221.
9.Simonsen O, Moller B, Dorflinger T, et al: The significance of age on symptoms and urodynamic and cystoscopic findings in benign prostatic hypertrophy. Urol Res 1987; 15: 355-358.
10.Stamey TA, Yang N, Hay AR, et al: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-914., 百拇医药(孙颖浩)
8.Schafer W, Noppeney R, Rhbben H, et al: The value of free flow rate and pressure/flow-study in the routine investigation of BPH patients. Neurourol Urodyn 1988; 7: 219-221.
9.Simonsen O, Moller B, Dorflinger T, et al: The significance of age on symptoms and urodynamic and cystoscopic findings in benign prostatic hypertrophy. Urol Res 1987; 15: 355-358.
10.Stamey TA, Yang N, Hay AR, et al: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-914., 百拇医药(孙颖浩)